Compared with Aug 24, 2026
Final monthly edition
PEPTIDEBENCHMARK MARKET INTELLIGENCE
August 2026
Peptide Price Index
Data through Aug 31, 2026INDEX VALUE126.51-0.7% 28 days
Baseline = 100 on Jun 3, 2026
Compared with Aug 3, 2026
Current lanes with at least three vendors
2,328 vendor observations
MARKET BREADTH
Tracked medians showed mixed direction
Movement is based on each peptide’s median effective price per milligram, with ±0.5% treated as approximately flat.
25down
18flat
17up
28-DAY MOVERS
The largest changes in median effective $/mg
These are market-lane medians—not a single vendor’s promotion or a claim about completed transactions.
Largest decreases
01Survodutide13 vendors · $8.95/mg-23.6%02Dihexa8 vendors · $7.65/mg-15.0%03PE-22-2816 vendors · $4.50/mg-13.8%04N-Acetyl Selank Amidate9 vendors · $3.33/mg-11.3%05Thymagen5 vendors · $2.75/mg-11.3%06CP-1C54 vendors · $9.04/mg-10.5%07LL-3738 vendors · $9.00/mg-10.0%08FOXO4-DRI20 vendors · $15.40/mg-7.2%Largest increases
01Oxytocin35 vendors · $7.50/mg+30.4%02CP-3R15 vendors · $7.59/mg+13.8%03PNC-2713 vendors · $11.51/mg+9.3%04Vilon10 vendors · $2.70/mg+9.1%05KPV85 vendors · $4.90/mg+8.9%06CP-1S11 vendors · $7.47/mg+8.7%07Livagen6 vendors · $2.65/mg+8.3%08GHRP-215 vendors · $3.70/mg+7.0%NEW OBSERVED LOWS
Median prices at a new tracked low
Requires at least 14 qualifying observations and three current vendors. Gaps are not interpolated.
MARKET DEPTH
The most broadly priced peptide lanes
Vendor and offer counts help readers distinguish broad market signals from thinner listings.
| Peptide | Vendors | Offers | Median effective / mg | Current low / mg | 28 day |
|---|---|---|---|---|---|
| MOTS-c ↗ | 100 | 205 | $3.98 | $0.8000 | +0.5% |
| BPC-157 ↗ | 100 | 193 | $5.40 | $0.8000 | -2.3% |
| GHK-Cu ↗ | 98 | 189 | $0.6500 | $0.1980 | -1.2% |
| TB-500 ↗ | 85 | 132 | $6.18 | $1.84 | 0.0% |
| Ipamorelin ↗ | 85 | 121 | $5.70 | $0.8800 | -3.0% |
| KPV ↗ | 85 | 108 | $4.90 | $0.8000 | +8.9% |
| PT-141 ↗ | 85 | 104 | $4.25 | $0.8000 | +0.0% |
| NAD+ ↗ | 84 | 149 | $0.1134 | $0.0400 | +0.1% |
| Selank ↗ | 84 | 116 | $4.41 | $0.8800 | -2.1% |
| Tesamorelin ↗ | 83 | 143 | $7.00 | $2.19 | -0.3% |
| Semax ↗ | 83 | 114 | $4.43 | $0.8800 | +4.2% |
| DSIP ↗ | 80 | 107 | $5.42 | $0.9300 | +0.3% |
METHODOLOGY & CITATION
What this report measures—and what it does not
Every edition carries its construction and coverage snapshot so later citations are interpreted against the data available at publication.
Tracked listing prices
Median effective USD per milligram across exact-comparability offers, using the discount rules recorded with each pricing snapshot.
Fixed-cohort index
Equal-weighted fixed cohort. Each eligible peptide is normalized to 100 at its first observation; daily index values average available normalized medians and require at least 70% cohort coverage.
Coverage limits
This is a tracked-listing index, not a transaction-price index. Vendor mix, availability, quantities, discounts, and catalog coverage can change over time.
SUGGESTED CITATION
PeptideBenchmark. “August 2026 Peptide Price Index Report.” Data through Aug 31, 2026. https://peptidebenchmark.com/prices/reports/2026-08/